EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Comprehensive HLA-DR4 MHC Class II Tetramer Platform for the Detection and Functional Validation of Post-Translational Modification Neoantigens

Henghui Li iD, Jingyao Li, Ying Wang, Hongyan Ma iD, Fen Tang, Liang Chen

International Journal of Molecular Sciences · 23.06.2026 · 27 (13) · 5660

DOI: 10.3390/ijms27135660 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.06.2026. Verfasst von Henghui Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Shanghai University, Shanghai 200444, China. Hauptthemen laut MEDLINE: Protein Processing, Post-Translational, HLA-DR4 Antigen. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Key Research and Development Program of China, the National Natural Science Foundation of China, the Major Program of the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Post-translational modification (PTM) neoantigens have emerged as key drivers of autoimmune inflammation. However, standardized protocols for MHC Class II tetramer preparation for the detection of such antigen-specific T cells remain limited, hindering the broader application of this important discovery. This study systematically engineered an HLA-DR4 (HLA-DRB1*04:02 and HLA-DRA*01:01) tetramer platform based on carboxyethyl-modified neoantigen ITGA2B peptide (ITG-CE), a PTM associated with autoimmune diseases (AUIDs) such as Ankylosing Spondylitis (AS). The platform provides a major histocompatibility complex (MHC) Class II tetramer associated with the PTM neoantigen and integrates modular protein construct, a controllable PTM peptide exchange strategy, and a specific T cell receptor (TCR) validation model. It can be employed to investigate PTM neoantigen presentation and CD4+ T cell auto-reactivity, providing extensive application value for future research into the mechanisms of PTM-induced AUIDs and immune monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Processing, Post-TranslationalHLA-DR4 AntigenHumansCD4-Positive T-LymphocytesReceptors, Antigen, T-CellHistocompatibility Antigens Class IISpondylitis, Ankylosing

Stichwörter der Autor:innen

HLA-DR4T-cell receptor (TCR) recognitionantigen-specific CD4+ T cellsautoimmune diseases (AUIDs)fluorescence polarization (FP)high-throughput screeningmajor histocompatibility complex (MHC) class II tetramerpost-translational modification (PTM) neoantigens

Substanzen

HLA-DR4 AntigenReceptors, Antigen, T-CellHistocompatibility Antigens Class II

Autor:innen und Institutionen

  • School of Medicine, Shanghai University, Shanghai 200444, China.

ORCID-Profile: Henghui Li, Hongyan Ma

Förderung

  • the National Key Research and Development Program of China
  • the National Natural Science Foundation of China
  • the Major Program of the National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Major Program of the National Natural Science Foundation of China

Zitieren

APA

Li, H., Li, J., Wang, Y., Ma, H., Tang, F., & Chen, L. (2026). A Comprehensive HLA-DR4 MHC Class II Tetramer Platform for the Detection and Functional Validation of Post-Translational Modification Neoantigens. International Journal of Molecular Sciences, 27(13), 5660. https://doi.org/10.3390/ijms27135660

Vancouver

Li H, Li J, Wang Y, Ma H, Tang F, Chen L. A Comprehensive HLA-DR4 MHC Class II Tetramer Platform for the Detection and Functional Validation of Post-Translational Modification Neoantigens. International Journal of Molecular Sciences. 2026;27(13):5660. doi:10.3390/ijms27135660

BibTeX
@article{Li2026,
  author = {Li, Henghui and Li, Jingyao and Wang, Ying and Ma, Hongyan and Tang, Fen and Chen, Liang},
  title = {A Comprehensive HLA-DR4 MHC Class II Tetramer Platform for the Detection and Functional Validation of Post-Translational Modification Neoantigens},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {13},
  pages = {5660},
  doi = {10.3390/ijms27135660}
}
Kostenlos starten →